SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-014072
Filing Date
2019-12-19
Accepted
2019-12-19 09:17:13
Documents
16
Period of Report
2019-12-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 31750
2 INVESTOR PRESENTATION ndra_ex991.htm EX-99.1 13116
3 IMAGE ndra_ex991000.jpg GRAPHIC 94874
4 IMAGE ndra_ex991001.jpg GRAPHIC 176995
5 IMAGE ndra_ex991002.jpg GRAPHIC 99688
6 IMAGE ndra_ex991003.jpg GRAPHIC 126961
7 IMAGE ndra_ex991004.jpg GRAPHIC 123291
8 IMAGE ndra_ex991005.jpg GRAPHIC 92453
9 IMAGE ndra_ex991006.jpg GRAPHIC 129205
10 IMAGE ndra_ex991007.jpg GRAPHIC 134314
11 IMAGE ndra_ex991008.jpg GRAPHIC 133555
12 IMAGE ndra_ex991009.jpg GRAPHIC 153793
13 IMAGE ndra_ex991010.jpg GRAPHIC 110493
14 IMAGE ndra_ex991011.jpg GRAPHIC 122961
15 IMAGE ndra_ex991012.jpg GRAPHIC 116040
16 IMAGE ndra_ex991013.jpg GRAPHIC 97823
  Complete submission text file 0001654954-19-014072.txt   2405727
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 191294272
SIC: 3845 Electromedical & Electrotherapeutic Apparatus